News

Healthline20h
First-Generation GLP-1 Drugs May Help Lower Risk of Obesity-Related Cancers
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
Medical News Today21h
Diabetes and weight loss drug semaglutide may also treat liver disease
A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...
Mass. residents who take GLP-1 drugs for obesity tend to be white and affluent. But who needs them most?
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
Rolling Out19h
Weight-loss injections slash cancer risk
Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...
Medscape20h
Rapid Weight Loss Can Trigger Emotional Turmoil
While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...
GLP-1 receptor agonists show anti-cancer benefits beyond weight loss
New research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May) and published in the ...
Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
GLP-1 drugs made a former FDA chief ‘feel ill.’ But he’d take them again.
David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of chronic ...